BY Oliver Bogler, Ph.D.

I finished the most active treatment phase for male breast cancer in the first week of June, enjoyed a few weeks off from regular clinic visits and am now back to join a clinical trial that I hope will help me stay disease free and make a contribution to the development of a new therapy to suppress breast cancer recurrence.

The trial is testing a relatively new approach, in which the immune...